Načítá se...

A serogroup A meningococcal polysaccharide vaccine: Studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A

Vaccination against cerebrospinal meningitis (CSM) has regained interest with the use of capsular polysaccharides (or polyosides) of the meningococcus as specific immunizing agents. These compounds proved to be effective in the USA against meningitis caused by Neisseria meningitidis serotype C. This...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Erwa, H. H., Haseeb, M. A., Idris, A. A., Lapeyssonnie, L., Sanborn, W. R., Sippel, J. E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1973
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2481142/
https://ncbi.nlm.nih.gov/pubmed/4211056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!